Pelvic lymph node dissection and prostate cancer-specific survival after surgery

According to an editorial commentary by Evans on the UroToday web site yesterday, a Canadian study published in BJU International last November has raised some interesting questions about the potential value of pelvic lymph node dissection (PLND) during the surgical treatment of men with prostate cancer of any stage. … READ MORE …

Fewer lymph node dissections and fewer positive lymph nodes: does it actually matter?

Surgical removal of samples of the pelvic lymph nodes at the time of radical prostatectomy (RP) — known as pelvic lymph node dissection (PLND)  — is still the most accurate method available to determine the presence or absence of lymph nodes positive for cancer (pN1 disease) in a patient with cancer of the prostate. … READ MORE …

Prostate cancer news reports: Saturday, July 25, 2009

Today’s news reports address items on:

  • The burden of prostate cancer in Canada
  • Pelvic lymph node dissection and RALP
  • Data from early trials of sipuleucel-T in advanced prostate cancer
  • Implementation of osteoporosis screening guidelines in prostate cancer patients … READ MORE …

More Tuesday news reports: April 21, 2009

In today’s other news reports there are items on:

  • Mistrust between patients and their doctors regarding prostate cancer issues
  • Use of a new, 3D transrectal ultrasound-guided biopsy system
  • Pelvic lymph node dissection and its extent in prostate cancer staging and outcome
  • Negative result of oblimersen sodium prior to docetaxel in castration-resistant prostate cancer … READ MORE …

Other Wednesday prostate cancer news: February 4, 2009

In addition to the reports on the early stages of the RALP learning curve and quality of life outcomes post-brachtherapy, there are a large number of additional reports in today’s news: … READ MORE …